Modus Therapeutics Holding AB (publ) (STO:MODTX)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.3700
+0.0110 (3.06%)
Jul 24, 2026, 4:51 PM CET

STO:MODTX Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-0.02-15.84-16.4-18.01-20.69
Net Income
-13.69-0.38-15.55-17.9-18.32-20.69
Earnings Per Share
-0.32-0.30-0.43-1.01-1.14-1.67
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
6.9311.374.3819.0610.4220.65
Total Debt
000011.50
Net Cash (Debt)
6.9311.374.3819.06-1.0820.65
Net Cash Growth
2066.56%159.72%-77.03%--181.12%
Net Cash Per Share
0.080.180.121.07-0.071.67

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-18.460.06-14.68-16.68-21.72-16.08
Free Cash Flow
-18.460.06-14.68-16.68-21.72-16.08
Free Cash Flow Growth
------

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
-322.80----